Desvenlafaxine
Also known as: Desvenlafaxine Succnt, Khedezla, Pristiq.
Wholesale (NADAC) cost for every strength and dosage form — the price pharmacies pay, published weekly by CMS. Not your out-of-pocket price.
Wholesale (NADAC) prices — every strength & form
| Strength | Form | NADAC / unit | Class |
|---|---|---|---|
| 25 MG | (unspecified) ER | $0.446 / unit | Generic |
| 25 MG | Tablet ER | $14.00 / unit | Brand |
| 50 MG | Tablet ER | $3.85 / unit | Generic |
| 50 MG | (unspecified) ER | $0.425 / unit | Generic |
| 100 MG | Tablet ER | $3.87 / unit | Generic |
| 100 MG | (unspecified) ER | $0.420 / unit | Generic |
Wholesale (NADAC) — the price pharmacies pay, not your out-of-pocket price. Brand list prices fall after confidential rebates.
NADAC week of 2026-07-01 · updated weekly · source CMS
Medicaid & Medicare spending · 2024
In 2024, Medicaid paid $32,560,241 gross for Desvenlafaxine across 711,668 prescriptions (measured, national).
Medicare Part D EST spent an estimated ~$69,006,519 gross (retail pharmacy only; excludes Part B).
Gross program spending, before rebates — not what patients pay out of pocket. Brand net cost is materially lower after confidential rebates; generics are close to net.
Source: Medicaid SDUD 2024 · Medicare Part D 2024 · CMS